BelHealth Investment Partners Mergers and Acquisitions Summary

Private Equity Firm Profile

BelHealth Investment Partners’ most common sectors for investment arehealthcare services (44%) and life science (25%) . The Firm’s most common investment types include buyout (lbo, mbo, mbi) (88%) and consolidation (7%). In total, BelHealth Investment Partners has invested in 11 US states.

In the last 3 years, BelHealth Investment Partners has exited 5 companies. The Firm’s most common exit type is trade sale (45%). BelHealth Investment Partners’ largest (disclosed) exit occurred in 2021 when it sold EasyDNA for $4M.

Join Mergr to view BelHealth Investment Partners’ full profile and discover more middle-market private equity firm investors just like it.

M&A Summary

  • M&A Total Activity24
    • M&A Buy Activity15
    • M&A Sell Activity9
  • Total Sectors Invested 5
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 6

BelHealth Investment Partners

BelHealth Investment Partners

401 E. Las Olas Boulevard, Suite 1400,
Fort Lauderdale, New York 33301
United States
(954) 636-3680
www.belhealth.com
info@belhealth.com

BelHealth Investment Partners LLC is a private equity firm focused on mid-sized healthcare companies. The Firm looks to invest $20 to $50 million per transaction and specifically targets healthcare services, healthcare products, healthcare distribution, and healthcare IT. BelHealth prefers companies with recurring revenue, high margins, diverse customers, low regulatory oversight, and modest technology risk. Prospective companies are typically profitable with at least $20-$100 million of enterprise value, $10-$100 million of revenue and $2-$10 million of EBITDA. BelHealth was formed in 2011 and is based in New York City.


Investment Criteria

Sectors of Interest: Healthcare Services, Information Technology, Life Science, Medical Products, Staffing

Target Transaction Types: Buyout (LBO, MBO, MBI), Consolidation, Recapitalization

Geographic Preferences: East US, Midwest US, South US, West US

Transaction Criteria Min Max
Target Revenue 10 100
Target EBITDA 2 10
Investment Size 20 50
Enterprise Value 20 100
values in millions of USD

M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 15 - - - - - 15
Sell (1.0/yr) # 4 - 4 - - 1 9
vol $4M $4M
  24

Most Recent M&A

Company Date Value Type
VFP Pharmacy Group 2024-08-08 - Unknown
Waltham, Massachusetts · www.vfppharmacygroup.com
American Health Staffing Group LLC 2021-11-22 - Secondary Sale
Edmond, Oklahoma · www.theahsg.com
American HealthCare Staffing Association LLC 2021-11-22 - Unknown
Traverse City, Michigan · www.ahsa.com
EasyDNA 2021-07-19 4M USD Trade Sale
Elk Grove, California · www.easy-dna.com
Care Advantage, Inc. 2021-06-01 - Secondary Sale
Richmond, Virginia · www.careadvantageinc.com
Gemini BioProducts LLC 2018-09-14 - Buyout (LBO, MBO, MBI)
West Sacramento, California · www.geminibio.com
NavaDerm Partners 2018-07-17 - Consolidation
New York, New York · www.navaderm.com
Beach House Center for Recovery 2018-06-28 - Buyout (LBO, MBO, MBI)
Juno Beach, Florida · www.beachhouserehabcenter.com
Apothecary By Design 2018-01-05 - Trade Sale
Portland, Maine · www.abdrx.com
Integrated Care Physicians, Inc. 2017-08-16 - Buyout (LBO, MBO, MBI)
Tampa, Florida · www.integratedcarephysicians.com
View All >>

Portfolio M&A

Company Acquired Add-On/Sale Date #
NavaDerm Partners 2018-07-17 Dermatology and Surgery Associates, Inc. 2024-11-15 3
New York, New York · www.navaderm.com Bronx, New York · www.dermatologyandsurgeryassociates.com
NavaDerm Partners 2018-07-17 Millburn Laser Center 2023-12-18 2
New York, New York · www.navaderm.com Millburn, New Jersey · www.millburnlaser.com
NavaDerm Partners 2018-07-17 Scherl Dermatology 2023-12-18 1
New York, New York · www.navaderm.com Englewood Cliffs, New Jersey · www.scherlmd.com
Gemini BioProducts LLC 2018-09-14 E.I. Spectra LLC 2022-10-27 1
West Sacramento, California · www.geminibio.com Ketchum, Idaho · www.orflo.com

M&A by Sector

Sector Current # Value All-time # Value
Healthcare Services 2 (50%) - 7 (44%) -
Life Science 2 (50%) - 4 (25%) -
Medical Products - - 2 (13%) -
Staffing - - 2 (13%) -
Information Technology - - 1 (6%) -
Total 4 - 16 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 4 (100%) - 16 (100%) -
  California 2 (50%) - 4 (25%) -
  New York 1 (25%) - 2 (13%) -
  Florida 1 (25%) - 2 (13%) -
  Virginia - - 1 (6%) -
  Pennsylvania - - 1 (6%) -
  Oklahoma - - 1 (6%) -
  New Mexico - - 1 (6%) -
  New Jersey - - 1 (6%) -
  Michigan - - 1 (6%) -
  Massachusetts - - 1 (6%) -
  Maine - - 1 (6%) -
Total 4 - 16 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Buyout (LBO, MBO, MBI) 2 (50%) - 14 (88%) -
Consolidation 1 (25%) - 1 (6%) -
Recapitalization 1 (25%) - 1 (6%) -
Total 4 - 16 -

Exits by Deal Type

Type Total # Value
Trade Sale - Public Company 2 (22%) 4M (100%)
Secondary Sale 2 (22%) -
Trade Sale 2 (22%) -
Unknown 2 (22%) -
Recapitalization 1 (11%) -
Total 9 $4M

Deal Values

sell # Total
< $100M 1 $4M
TOTAL $4M
Largest EasyDNA
$4M (2021-07-19)

M&A Connections

Deals
Acquired from
Investor(s)
6%
1 (6%)
Exited to
Investor(s)
33%
3 (33%)
Strategic(s)
44%
4 (44%)

Investor Summary

Investor Type

Private Equity Firm

Size

Middle-Market

PE Assets

500M USD

Established

2011

Specialist/Generalist

Generalist

Leadership

Dennis Drislane

Co-Founder & Managing Partner

Harold Blue

Co-Founder & Managing Partner

Joseph Wynne

CFO & CCO

Inder Tallur

Partner

Jaimie Paul

Human Resources & Compliance Director

FAQ

When was BelHealth Investment Partners founded?

BelHealth Investment Partners was founded in 2011.

What type of investor is BelHealth Investment Partners?

BelHealth Investment Partners is a private equity firm.

Where is BelHealth Investment Partners headquartered?

BelHealth Investment Partners is headquartered in Fort Lauderdale, New York.

How much capital does BelHealth Investment Partners have under management?

BelHealth Investment Partners has 500M USD under management.

 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal